The success rate for vaccines is even lower than for biopharmaceutical drugs, by some accounts. In an attempt to turn things around and address long-standing vaccinology problems, Wayne Koff, Chief Scientific Officer at the International AIDS Vaccine Initiative (IAVI), and colleagues proposed a Human Vaccines Project in 2013. Top vaccinologists met to outline a scientific approach and business strategy in 2014, and the Human Vaccines Project could now launch by this summer, Koff tells Asher Mullard.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Rights and permissions
About this article
Cite this article
Wayne Koff. Nat Rev Drug Discov 14, 10 (2015). https://doi.org/10.1038/nrd4528
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd4528
